Lisa Bloudek completed her Doctor of Pharmacy at the University of Washington (UW) School of Pharmacy and her Master of Science from the UW Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute. Lisa established her health economics and outcomes research (HEOR) career in the global HEOR group at Allergan supporting the global launch of BOTOX for chronic migraine. Prior to founding Curta, Lisa gained experience in numerous research projects and developed economic-modeling expertise as a member of the modeling team for an established HEOR consulting firm. She previously held an appointment as senior research scientist at the CHOICE Institute to conduct cost-effectiveness evaluations for the Institute for Clinical and Economic Review (ICER).